Collegium Pharmaceutical, Inc. (COLL)
24.72
+0.51
(+2.11%)
USD |
NASDAQ |
Nov 09, 09:59
Collegium Pharmaceutical Debt to Equity Ratio : 4.074 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.074 |
| June 30, 2026 | 3.905 |
| March 31, 2026 | 2.976 |
| December 31, 2025 | 3.104 |
| September 30, 2025 | 3.407 |
| June 30, 2025 | 4.099 |
| March 31, 2025 | 4.119 |
| December 31, 2024 | 4.282 |
| September 30, 2024 | 4.239 |
| June 30, 2024 | 2.583 |
| March 31, 2024 | 2.836 |
| December 31, 2023 | 3.450 |
| September 30, 2023 | 4.016 |
| June 30, 2023 | 3.796 |
| March 31, 2023 | 4.486 |
| December 31, 2022 | 3.640 |
| September 30, 2022 | 3.713 |
| June 30, 2022 | 3.820 |
| March 31, 2022 | 3.966 |
| December 31, 2021 | 1.275 |
| September 30, 2021 | 1.078 |
| June 30, 2021 | 1.116 |
| March 31, 2021 | 1.731 |
| December 31, 2020 | 1.433 |
| Date | Value |
|---|---|
| September 30, 2020 | 1.602 |
| June 30, 2020 | 1.841 |
| March 31, 2020 | 2.105 |
| December 31, 2019 | 0.247 |
| September 30, 2019 | 0.2595 |
| June 30, 2019 | 0.2568 |
| March 31, 2019 | 0.2561 |
| December 31, 2018 | 0.1256 |
| September 30, 2018 | 5.830 |
| June 30, 2018 | 5.331 |
| March 31, 2018 | 5.354 |
| December 31, 2017 | 0.0142 |
| September 30, 2017 | 0.0223 |
| June 30, 2017 | 0.0295 |
| March 31, 2017 | 0.0304 |
| December 31, 2016 | 0.0307 |
| September 30, 2016 | 0.0648 |
| June 30, 2016 | 0.0555 |
| March 31, 2016 | 0.0505 |
| December 31, 2015 | 0.0801 |
| September 30, 2015 | 0.0801 |
| June 30, 2015 | 0.0758 |
| March 31, 2015 | 0.2305 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 0.9531 |
| Corcept Therapeutics, Inc. | 0.0108 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5477 |
| Eli Lilly & Co. | 1.229 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.096B |
| Total Liabilities (Quarterly) | 1.799B |
| Shareholders Equity (Quarterly) | 296.44M |
| Current Ratio | 1.014 |
| Net Debt Paydown Yield | -7.55% |